Janus Henderson Group’s Larimar Therapeutics LRMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,571,963	Closed	-$13.1M	–	2469
2025 Q1	$13.1M	Sell	5,571,963 -871,323	-14%	-$2.75M	0.01%	657
2024 Q4	$24.9M	Buy	6,443,286 +876,431	+16%	+$5.79M	0.01%	533
2024 Q3	$36.4M	Buy	5,566,855 +1,189,467	+27%	+$9.56M	0.02%	454
2024 Q2	$31.6M	Buy	4,377,388 +356,423	+9%	+$2.73M	0.02%	483
2024 Q1	$30.5M	Buy	4,020,965 +1,379,900	+52%	+$10.8M	0.02%	486
2023 Q4	$12M	Buy	2,641,065 +179,603	+7%	+$606K	0.01%	634
2023 Q3	$9.71M	Buy	2,461,462 +1,015,736	+70%	+$3.84M	0.01%	670
2023 Q2	$4.53M	Buy	1,445,726 +375,295	+35%	+$1.53M	﹤0.01%	888
2023 Q1	$4.86M	Buy	1,070,431 +143,162	+15%	+$748K	﹤0.01%	882
2022 Q4	$3.82M	Sell	927,269 -672,731	-42%	-$2.3M	﹤0.01%	920
2022 Q3	$5.14M	Buy	1,600,000 +850,932	+114%	+$2.13M	﹤0.01%	989
2022 Q2	$1.48M	Sell	749,068 -296,177	-28%	-$875K	﹤0.01%	1152
2022 Q1	$4.22M	Buy	1,045,245 +310,133	+42%	+$2.03M	﹤0.01%	1047
2021 Q4	$7.92M	Buy	735,112 +93,997	+15%	+$1.05M	﹤0.01%	951
2021 Q3	$7.46M	Buy	641,115 +40,155	+7%	+$482K	﹤0.01%	960
2021 Q2	$5.89M	Buy	600,960 +458,613	+322%	+$5.18M	﹤0.01%	1031
2021 Q1	$2.08M	Buy	142,347 +3,602	+3%	+$65.4K	﹤0.01%	1183
2020 Q4	$2.97M	Sell	138,745 -24,854	-15%	-$498K	﹤0.01%	1063
2020 Q3	$2.54M	Buy	+163,599	New	+$2.07M	﹤0.01%	1020